Lista de obras - Orietta Picconi - Dominio Público Uruguay

BDNF Val66Met polymorphism and brain volumes in multiple sclerosis

artículo científico publicado en 2010

Building up a collaborative network for the surveillance of HIV genetic diversity in Italy. A pilot study

artículo científico publicado en 2015

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

artículo científico publicado en 2011

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

artículo científico publicado en 2009

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine

artículo científico publicado en 2015

Development of the Italian Version of the National Institutes of Health Stroke Scale

artículo científico publicado en 2009

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

scientific article published on 07 December 2009

Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals

artículo científico publicado en 2003

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

artículo científico publicado en 2020

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

artículo científico publicado en 2015

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies

artículo científico publicado en 2012

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

artículo científico publicado en 2016

HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction

artículo científico publicado en 2020

Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

artículo científico publicado en 2011

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure

artículo científico publicado en 2005

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms

artículo científico publicado en 2014

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients ⬇️

artículo científico publicado en 2011

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

artículo científico publicado en 2011

Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study ⬇️

artículo científico publicado el 1 de marzo de 2009

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

artículo científico publicado en 2013

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

artículo científico publicado en 2014

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

artículo científico publicado en 2010

Lista de obras de Orietta Picconi

BDNF Val66Met polymorphism and brain volumes in multiple sclerosis

Building up a collaborative network for the surveillance of HIV genetic diversity in Italy. A pilot study

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine

Development of the Italian Version of the National Institutes of Health Stroke Scale

Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis

Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals

HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction

Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure

Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients ⬇️

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study ⬇️

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART